z-logo
Premium
Synthesis and characterization of N ‐(2‐chloro‐5‐methylthiophenyl)‐ N ′‐(3‐methylthiophenyl)‐ N ′‐[ 11 C]methylguanidine [ 11 C]CNS 5161, a candidate PET tracer for functional imaging of NMDA receptors
Author(s) -
Zhao Yongjun,
Robins Edward,
Turton David,
Brady Frank,
Luthra Sajinder K.,
Årstad Erik
Publication year - 2006
Publication title -
journal of labelled compounds and radiopharmaceuticals
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.432
H-Index - 47
eISSN - 1099-1344
pISSN - 0362-4803
DOI - 10.1002/jlcr.1033
Subject(s) - radiosynthesis , chemistry , nmda receptor , positron emission tomography , receptor , ligand (biochemistry) , desmethyl , radiochemistry , neuroscience , biochemistry , psychology , metabolite
N ‐methyl‐ D ‐aspartate (NMDA) receptors play a key role in excitatory neurotransmission and are linked to a variety of acute and chronic neurodegenerative diseases including epilepsy, schizophrenia, Parkinson's disease and drug abuse. N ‐(2‐chloro‐5‐methylthiophenyl)‐ N ′‐(3‐methylthiophenyl)‐ N ′‐methylguanidine (CNS 5161) is a high affinity ligand (Ki=1.87±0.25 nM) for the NMDA PCP site, which potentially can be used for functional imaging of this receptor. Herein we report the synthesis of the corresponding positron emission tomography (PET) tracer [ 11 C]CNS 5161 by means of [ 11 C]methylation of the desmethyl guanidine precursor. [ 11 C]CNS 5161 was synthesized with a decay corrected radiochemical yield of 10% within 45 min after end of bombardment (EOB). The final product was prepared in a sterile saline solution suitable for clinical studies with a radiochemical purity of >96% and a specific activity of 41 GBq/mmol at time of injection. Copyright © 2005 John Wiley & Sons, Ltd.

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom